Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
» Mark Lawson
Mark Lawson
Articles
ARTICLES
Court Documents Reveal GSK's Stand On Relenza
June 15, 2005
By
Mark Lawson
Court Documents Reveal GSK's Stand On Relenza
June 15, 2005
By
Mark Lawson
Investor Interest Wanes For Australia's Biotech Stocks
April 20, 2005
By
Mark Lawson
Investor Interest Wanes For Australia's Biotech Stocks
April 20, 2005
By
Mark Lawson
Australian Stock Exchange: Commissioned Reports OK
Feb. 9, 2005
By
Mark Lawson
Australian Stock Exchange: Commissioned Reports OK
Feb. 9, 2005
By
Mark Lawson
Metabolic Jumps, Slides On Trial Data, Analyst Criticism
Dec. 22, 2004
By
Mark Lawson
Metabolic Jumps, Slides On Trial Data, Analyst Criticism
Dec. 22, 2004
By
Mark Lawson
Peptech, J&J Unit Centocor Settle Remicade IP Dispute
Nov. 24, 2004
By
Mark Lawson
Peptech, J&J Unit Centocor Settle Remicade IP Dispute
Nov. 24, 2004
By
Mark Lawson
View All Articles by Mark Lawson
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe